News > All

Total search results: 12024 | Ordered by Date (descending)
1 2 3 ... 119 120 121  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. 2019-08-20
Bayer AG. (8/20/19). "Press Release: Bayer to Sell Its Animal Health Business Unit to Elanco for 7.6 Billion U.S. Dollars". Leverkusen. 2019-08-20
Uniqure N.V.. (8/20/19). "Press Release: Uniqure Announces Leadership Promotions and Executive Transition". Lexington, MA & Amsterdam. 2019-08-20
Genentech, Inc.. (8/19/19). "Press Release: Retirement of Dr. Sandra Horning & Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech". South San Francisco, CA. 2019-08-19
Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. 2019-08-19
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. 2019-08-19
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-08-16
Roche. (8/16/19). "Press Release: FDA Approves Roche’s Rozlytrek (entrectinib) for People with ROS1-positive, MMetastatic Non-small Cell Lung Cancer and NTRK Gene Fusion-positive Solid Tumours". Basel. 2019-08-16
iTeos Therapeutics S.A.. (8/13/19). "Press Release: iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer". Gosselies & Cambridge, MA. 2019-08-13
Pharming Group N.V.. (8/13/19). "Press Release: Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS". Leiden. 2019-08-13
Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. 2019-08-13
Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. 2019-08-12
908 Devices, Inc.. (8/12/19). "Press Release: 908 Devices Launches the Rebel, the First At-line Spent Cell Media Analyzer for Bioprocess Labs". Boston, MA. 2019-08-12
Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. 2019-08-12
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
Curetis N.V.. (8/12/19). "Press Release: Curetis Retains H.C. Wainwright & Co. as Strategic Advisor". Amsterdam & Holzgerlingen. 2019-08-12
Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. 2019-08-12
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. 2019-08-08
Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. 2019-08-08
BlueRock Therapeutics. (8/8/19). "Press Release: Bayer Acquires BlueRock Therapeutics to Build Leading Position in Cell Therapy". Berlin & Cambridge, MA. 2019-08-08
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. 2019-08-07
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-08-07
Stemline Therapeutics, Inc.. (8/7/19). "Press Release: Stemline Therapeutics Announces Proposed Public Offering of Common Stock". New York, NY. 2019-08-07
Stemline Therapeutics, Inc.. (8/7/19). "Press Release: Stemline Therapeutics Announces Pricing of $76,250,000 Public Offering of Common Stock". New York, NY. 2019-08-07
Eurofins Genomics LLC. (8/6/19). "Press Release: Eurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron Biotech". Louisville, KY. 2019-08-06
ADC Therapeutics S.A.. (8/6/19). "Press Release: ADC Therapeutics and Sophia Genetics Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial". Lausanne. 2019-08-06
Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. 2019-08-06
NMI TT Pharmaservices. (8/6/19). "Press Release: LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development". Lincoln, NE. 2019-08-06
BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv. 2019-08-06
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
GNA Biosolutions GmbH. (8/5/19). "Press Release: GNA Biosolutions Closes $13.5M Series C Financing Round Backed by a US/EU consortium". Munich. 2019-08-05
Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA. 2019-08-05
Inveox GmbH. (8/5/19). "Press Release: 17 Million for Future Cancer Diagnoses. Inveox Acquires Further Investment". Munich. 2019-08-05
Roche. (8/5/19). "Press Release: Roche’s Tecentriq plus Platinum-based Chemotherapy Reduced the Risk of Disease Worsening or Death in People with Previously Untreated Advanced Bladder Cancer". Basel. 2019-08-05
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". 2019-08-02
Thrive Earlier Detection Corporation. (8/1/19). "Press Release: Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer". Cambridge, MA. 2019-08-01
Bruker Corporation. (8/1/19). "Press Release: Bruker Reports Second Quarter 2019 Financial Results". Billerica, MA. 2019-08-01
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2019 Cash Position and Provides Corporate Update". Boston, MA. 2019-08-01
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. 2019-08-01
Curetis N.V.. (8/1/19). "Press Release: Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes". Amsterdam, San Diego, CA & Holzgerlingen. 2019-08-01
Vida Ventures. (8/1/19). "Press Release: Vida Ventures Closes $600 Million Vida II Fund to Support Life Science Innovation". Boston, MA. 2019-08-01
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. 2019-08-01
Pieris Pharmaceuticals, Inc.. (8/1/19). "Press Release: Pieris Pharmaceuticals Appoints Dr. Maya Said to its Board of Directors". Boston, MA. 2019-08-01
Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. 2019-07-31
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. 2019-07-31
Sirion Biotech GmbH. (7/31/19). "Press Release: Gene and Cell Therapy Solutions Provider, Sirion Biotech Announces Record First Half 2019 Financial Results". Munich. 2019-07-31
Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon. 2019-07-31
Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund. 2019-07-31
AgroSavfe N.V.. (7/30/19). "Press Release: AgroSavfe Raises €35 million in Series C Financing". Ghent. 2019-07-30
Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. 2019-07-29
Exact Sciences Corporation. (7/29/19). "Press Release: Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company". Madison, WI & Redwood City, CA. 2019-07-29
Twist Bioscience Corporation. (7/25/19). "Press Release: Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA". San Francisco, CA. 2019-07-25
Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. 2019-07-25
Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. 2019-07-25
Fluidigm Corporation. (7/25/19). "Press Release: Bill W. Colston Named to Fluidigm Board of Directors". South San Francisco, CA. 2019-07-25
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
Qiagen N.V.. (7/24/19). "Press Release: Qiagen Reports Results for Second Quarter of 2019 – Updates Full-year 2019 Outlook Due to Decision to Restructure China NGS Partnership". Venlo. 2019-07-24
Freenome, Inc.. (7/24/19). "Press Release: Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detection". South San Francisco, CA. 2019-07-24
Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. 2019-07-23
Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. 2019-07-22
Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. 2019-07-22
Marker Therapeutics, Inc.. (7/20/19). "Press Release: Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR". San Francisco, CA. 2019-07-20
AvroBio, Inc.. (7/19/19). "Press Release: AvroBio Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridge, MA. 2019-07-19
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
Genmab A/S. (7/19/19). "Press Release: Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering". Copenhagen. 2019-07-19
Gilead Sciences, Inc.. (7/19/19). "Press Release: Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis". Foster City, CA. 2019-07-19
Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. 2019-07-18
ImCheck Therapeutics S.A.S.. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. 2019-07-18
Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. 2019-07-18
MyoKardia, Inc.. (7/18/19). "Press Release: MyoKardia Announces HCM Program Updates". South San Francisco, CA. 2019-07-18
Precision BioSciences Inc.. (7/18/19). "Press Release: Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States". Durham, NC. 2019-07-18
Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt. 2019-07-18
Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. 2019-07-18
Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. 2019-07-18
Merck KGaA. (7/18/19). "Press Release: Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation". Darmstadt. 2019-07-18
Bayer AG. (7/17/19). "Press Release: Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer". Leverkusen & Boston, MA. 2019-07-17
Bruker Corporation. (7/17/19). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. 2019-07-17
Immunic, Inc.. (7/16/19). "Press Release: Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer". San Diego, CA. 2019-07-16
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. 2019-07-16
Novartis AG. (7/16/19). "Press Release: FDA Accepts File and Accelerates Review of Novartis Sickle Cell Disease Medicine Crizanlizumab (SEG101)". Basel. 2019-07-16
Evogene Ltd.. (7/16/19). "Press Release: Evogene Amends Its Collaboration Agreement with Bayer to Include Genome Editing Targets". Rehovot. 2019-07-16
Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. 2019-07-15
Galapagos N.V.. (7/14/19). "Press Release: Gilead and Galapagos Enter into Transformative Research and Development Collaboration". Foster City, CA & Mechelen. 2019-07-14
North Carolina Biotechnology Centre. (7/12/19). "Press Release: Raleigh to Host 2020 BIO World Congress on Industrial Biotechnology and Ag Tech". 2019-07-12
Hookipa Pharma Inc.. (7/11/19). "Press Release: Hookipa Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers". New York, NY & Vienna. 2019-07-11
Agilent Technologies Inc.. (7/11/19). "Press Release: Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment". Santa Clara, CA. 2019-07-11
Novartis AG. (7/11/19). "Press Release: Novartis, Amgen and Banner Alzheimer's Institute Discontinue Clinical Program with BACE inhibitor CNP520 for Alzheimer's Prevention". Basel. 2019-07-11
Revolution Medicines, Inc.. (7/9/19). "Press Release: Revolution Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers". Redwood City, CA. 2019-07-09
ADC Therapeutics S.A.. (7/9/19). "Press Release: ADC Therapeutics Announces Final Close of Series E Financing Expansion". Lausanne. 2019-07-09
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. 2019-07-09
Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. 2019-07-09
Celsius Therapeutics Inc.. (7/9/19). "Press Release: Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis". Cambridge, MA. 2019-07-09
Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. 2019-07-08
Bruker Corporation. (7/8/19). "Press Release: Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies LLC". Zurich. 2019-07-08
Biophytis S.A.. (7/8/19). "Press Release: Biophytis Announces the Launch of its Public Offering on Nasdaq". Paris & Cambridge, MA. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
1 2 3 ... 119 120 121  next pagenext page



Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [iito] – Putting Information into Context 600x60px

» top